Features

Radiation Oncology

Chair: Jeffrey Forman, MD
1^st Level University Health Center
(313) 745-9191

Articles
Aref A, Thornton D, Youssef E, He T, Tekyi-Mensah S, Denton L, Ezzel G. Dosimetric improvements following 3D planning of tangential breast irradiation. International Journal Radiation Oncology, Biology Physics, Vol. 48, No. 5, 1569-74, 2000 Dec 1.

Beyer, D., Nath, R., Butler, W., Merrick, G., Blasko, J., Nag, S., Orton, C. “American Brachytherapy Society Recommendations for Clinical Implementation of NIST-1999 Standards for ¹⁰³Pd Brachytherapy.” Int. J. Radiat. Oncol. Biol. Phys. 47, 273-275, 2000.

Burmeister J, Kota C, Maughan RL, Spokas JJ, Coderre JA, Ma R,Wielopolski L. A conducting plastic simulating brain tissue. Medical Physics 27: 2560-2564, 2000.

Fisher RI, Dana BW, LeBlanc M, Kjeldsberg C, Forman JD, Unger JM, Balcerzak SP, Gaynor ER, Roy V, Miller T. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin’s lymphoma: results of the Southwest Oncology Group randomized phase III study 8809. J Clin Oncol. 2000 May; 18(10):2010-2016.

Forman JD, Lee WR, Roach M, Perez CA, Beyer DC, Blasko JC, Hussey DH, Paryani SB, Pollack A, Potters L, Scardino P, Schellhammer P, Leibel S. Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Jun; 215 Suppl:1373-1382.

Gomella LG, Albertsen PC, Benson MC, Forman JD, Soloway MS. The use of video-based patient education for shared decision-making in the treatment of prostate cancer. Semin Urol Oncol. 200 Aug; 18(3):182-187.

Gray, J.E. and Orton, C.G. “Medical Physics: Some Recollections in Diagnostic X-ray Imaging and Therapeutic Radiology.” Radiology 217, 619-625, 2000.

Jadhav M, Langenburg S, Fontanesi J, Slovis TL, Taub JW. Hepatoblastoma with spinal metastases. J Ped /Onc 22(6):524-526, November/December 2000.

Kim HE, Krug MA, Han I, Ensley JF, Forman J, Kim HC. Neutron radiation enhances cisplatin cytotoxicity independently of apoptosis in human head and neck carcinoma cells. Clinical Cancer Research, Vol. 6 (10) 412-417, 2000

Lee WR, Pollack A, Perez CA, Beyer DC, Blasko JC, Forman JD, Hussey DH, Paryani SB, Potters L, Roach M, Scardino P, Schellhammer P, Leibel S. Node positive prostate cancer. Amcerican College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Jun; 215 Suppl:1413-1418.

Nag, S., Erickson, B., Thomadsen, B., Orton, C., Demanes, J., Petereit, D. “The American Brachytherapy Society Recommendation for High-Dose Rate Brachytherapy for Carcinoma of the Cervix. Int. J. Radiat. Oncol. Biol. Phys. 48, 201-211, 2000.

Orton, C.G. and Croft, B.Y. “With the Expectation that Cancer Detection and Treatment will Occur Increasingly at the Molecular and Gene Levels Medical Physics Trainees Should Take Courses in Molecular Biology and Genetics.” Med. Phys. 27, 1209-1211, 2000.

Perez CA, Beyer DC, Blasko JC, Forman JD, Hussey DH, Lee WR, Paryani SB, Pollack A, Potters L, Roach M, Scardino P, Schellhammer P, Leibel S. Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Jun; 215 Suppl:1449-1472.

Perez CA, Beyer DC, Blasko JC, Forman JD, Hussey DH, Lee WR, Paryani SB, Pollack A, Potters L, Roach M, Scardino P, Schellhammer P, Leibel S. Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Jun 215 Suppl:1419-1439.

Pollack A, Paryani SB, Hussey D, Perez CA, Beyer DC, Blasko JC, Forman JD, Lee WR, Potters L, Roach M, Scardino P, Schellhammer P, Leibel S. Locally advanced (high-risk) prostate cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 June; 215 Suppl: 1401-1412.

Potters L, Perez CA, Beyer DC, Blasko JC, Forman JD, Hussey DH, Lee WR, Paryani SB, Pollack A, Roach M, Scardino P, Schellhammer P, Leibel S. Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun; 215:1383-1400.

Roach M, Blasko JC, Perez CA, Beyer DC, Forman JD, Hussey DH, Lee WR, Paryani SB, Pollack A, Potters L, Scardino P, Schellhammer P, Leibel S. Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000; Jun 215 Suppl:1441-1448.

Van den Heuval F, Forman JD, Tekyi-Mensah S, Ko HJ, Kim HE. Efficiency of network electronic portal imaging. Int. J. Radi. Onco. Bio. Phys (in press).

Yoo G, Washington J, Olicer J, Piechocki M, Kim HE, Foster-Nora J, Wilson D, Tainsky M, Ensley JF. The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes. Cancer Research (in press).

Yoo, G, Washington J, Foster-Nora J, Ensley J, Piechocki M, Shibuya T, Kim HE, Wei W. The effect of Docetaxel on head and neck preneoplastic cells. Cancer Research (in press).

Youssef E, Tekyi-Mensah S, Hart K, Bolton S, Forman J. The prognostic significance of changes in prostate specific antigen level during the course of therapeutic post-prostatectomy irradiation. J Urol (in press)

Books, Chapters and Reviews
Porter AT, Ben-Josef E, Garde SV. Humoral Mechanisms in Prostate Cancer – A Role for FSH. Institute for Medical Studies, April 2000.

Brenner, D., Dale, R., Orton, C.G., Fowler, J. “Modeling HDR, LDR and PDR.” In: Brachytherapy, Joslin, Hall and Flynn (Eds), Chapman and Hall, London (In Press).

Porter AT, Ben-Josef E. Humoral Mechanisms in Prostate Cancer: A Role for FSH. Urologic Oncology (in press).

Kim HE. Unusual head and neck cancers: Adenoid cystic carcinoma and unknown primaries. In: Head and Nack Cancer, (Ensley JF, Gutkind JS, Lippman SM), Academic Press, San Diego (in press).

Hillman GG. Experimental animal models for renal cell carcinoma. In: Teicher, BA (eds). Tumor Models in Cancer Research. Humana Press, Inc. In press

Abstracts
Ahmad F, Yap J, Arlauskas P, Tekyi-Mensah S, Philip P, Shields A, Vaitkevicius V, Levin K, Frazier, A, Forman, JD. Radiotherapy and chemotherapy in neoadjuvant and adjuvant settings for adenocarcinoma of the pancreas. Presented RSNA, Chicago Illinois, December 2000.

Balani J, Shields A, Vaitkevicius V, Ben-Josef E, Levin K, Sarkar F, Cheng J, Adsay V. Pathological findings in post-neoadjuvant pancreatectomy specimens. United States and Canadian Academy of Pathology.

Ben-Josef E. Chemoradiotherapy for localized high-risk prostate cancer. Proceedings of the European Society for Therapeutic Radiology and Oncology 19th Annual Meeting. Radiotherapy and Oncology, 2000.

Burmeister, J. Specification of the physical and biologically effective absorbed dose in radiation therapies utilizing the boron neutron capture reaction. Medical Physics 27: 266, 2000.

Forman, JD, DeYoung, C, Tekyi-Mensah S, Bolton S, Grignon D. The prognostic significance of the worst vs. overall glason score in patients with multiple positive prostate needle biopsies. Proceedings of the American Society for Therapeutic Radiology and Oncology, 42^nd Annual Meeting, October 22-26, 2000, Boston, MA. #188 International Journal of Radiation Oncology, Biology, Physics. Vol. 48, No. 5, Supplement 2000.

Forman JD, Tekyi-Mensah S, Bolton SE, Chuba PJ, Ben-Josef E, Porter AT, Maughan RL. Results of a randomized prospective trial of sequential neutron-photon versus photon-neutron irradiation in organ confined prostate cancer. American Urological Association 95th Annual Meeting, Atlanta, Georgia, April 29-May 4, 2000.

Frazier A, Kaufman N, Lutz M, Seifer J, Rosemberg S, Arterbery V, Relle J, Dalmia P, Forman J. The effect of neoadjuvant androgen ablation on the physical parameters and preliminary outcome for patients undergoing transrectal ultrasound guided I-125 permanent prostate implantation. The 82nd Annual Meeting of the American Radium Society, London, England. April 2000.

Frazier A, Kaufman N, Rosemberg S, Frazier R, Lutz M, Maitland C, Siefer J, Arterbery V, Dalmia P, Forman J. Prostate volume reduction induced by neoadjuvant androgen ablation in preparation for permanent radioactive seed. Presented at the 2^nd Joint International Meeting.ABS/GEC-Estro/Glac, Crystal City, Virginia, Radiotherapy Oncology, May 2000, Vol. 55 Supplement 1, p. 77

Hart KB, Do H, Weiss L, Forman J. The epidemiology of bilateral breast cancer. Proc RSNA. Radiol 2000 Nov 217:420

Hillman GG, Maughan RL, Grignon DJ, Yudelev M, Ramos JA, Tekyi-Mensah SE, Layer A, Chuba PJ, Forman JD. :Prostate tumor irradiation with photons or neutrons enhances the effect of immunotherapy for metastatic prostate cancer. First International Conference on Translational Research and Pre-Clinical Strategies in Radio-Oncology. ICRT 2000. Lugano, Switzerland, March 5-8th, 2000.

Korkmaz H, Yoo G, Jacobs J, Adsay V, Yap J, Tekyi-Mensah S, Sakr W, Kim HE. Prognostic importance of p27 and p53 in early laryngeal cancer, Proceedings of American Radium Society 82^nd Annual Meeting, 33, 2000.

Korkmaz H, Jacbos JR, Adsay V, Yap J, Tekyi-Mensah S, Yoo GH, Sakr W, Kim H. Prognostic importance of p27 and p53 in early laryngeal cancer. #55 Abstracts of the ARS Annual Meeting. The Cancer Journal, Vol. 6, No. 6, November/December 2000.

2000 Report to Investors:
Creating Personal Partnerships

Partnerships for Life

The Quest to Improve Women's Health

Gifts from Alumni

Gifts from Faculty, Staff, Friends and Corporations

2000/2001 Alumni Annual Telefund Volunteers

2000 New Endowed Funds at the School of Medicine

Alumni Contact Information

Bibliographies:
Anatomy and Cell Biology

Barbara Ann Karmanos Cancer Institute

Biochemistry and Molecular Biology

Center for Healthcare Effectiveness Research